USA – Experts urge transparency, advisory committee review for COVID-19 vaccines

At a virtual briefing on Tuesday, several experts told members of the House Committee on Oversight and Reform Subcommittee on Economic and Consumer Policy that a transparent process and advisory committee review will be key to the effective rollout of a vaccine to prevent coronavirus disease (COVID-19).

The briefing comes just two weeks after the US Food and Drug Administration (FDA) issued guidance on the development and licensure of vaccines against SARS-CoV-2, the virus that causes COVID-19, and at a time when some of the most advanced vaccine candidates are moving into Phase 3 trials. (RELATED: FDA issues COVID-19 vaccine guidance, setting 50% effectiveness thresholdRegulatory Focus 30 June 2020; Marks on COVID-19 vaccine efficacy, EUAs and challenge trialsRegulatory Focus 9 July 2020)…